Bill Text: HI HB2096 | 2020 | Regular Session | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Relating To Health.

Spectrum: Strong Partisan Bill (Democrat 13-1)

Status: (Introduced - Dead) 2020-02-07 - Passed Second Reading as amended in HD 1 and referred to the committee(s) on CPC/JUD with none voting aye with reservations; none voting no (0) and Representative(s) McDermott, Yamashita excused (2). [HB2096 Detail]

Download: Hawaii-2020-HB2096-Introduced.html

HOUSE OF REPRESENTATIVES

H.B. NO.

2096

THIRTIETH LEGISLATURE, 2020

 

STATE OF HAWAII

 

 

 

 

 

 

A BILL FOR AN ACT

 

 

RELATING TO HEALTH.

 

 

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

 


     SECTION 1.  Chapter 328, Hawaii Revised Statutes, is amended by adding a new section to be appropriately designated and to read as follows:

     "§328-    Cannabidiol products; product testing.  (a)  All products containing cannabidiol or marketed or sold as containing cannabidiol shall only be sold in the State if:

     (1)  The product has a certificate of analysis prepared by an independent testing laboratory that states the product does not contain contaminants unsafe for human consumption and contains a total delta-9-tetrahydrocannabinol concentration that does not exceed 0.3 per cent on a dry-weight basis pursuant to the testing of a random sample of the batch; and

     (2)  The product is sold or distributed in packaging that includes:

          (A)  A scannable barcode or quick reference code linked to the certificate of analysis of the product by an independent testing laboratory;

          (B)  The batch number;

          (C)  The internet address of a website where batch information may be obtained;

          (D)  The expiration date;

          (E)  The number of milligrams of cannabidiol;

          (F)  A statement that the product contains a total delta-9-tetrahydrocannabinol concentration that does not exceed 0.3 per cent on a dry-weight basis; and

          (G)  A statement certifying that the product is free from contaminants that are unsafe for human consumption.

     (b)  For purposes of this section, "independent testing laboratory" means a laboratory that:

     (1)  Does not have a direct or indirect interest in the entity whose product is being tested;

     (2)  Does not have a direct or indirect interest in a facility that cultivates, distributes, dispenses, or sells cannabidiol, hemp, or hemp extract in the State or in another jurisdiction; cultivates, processes, distributes, or sells marijuana, as defined in sections 329-1 and 712-1240; or holds a medical cannabis dispensary license pursuant to chapter 329D; and

     (3)  Is accredited by a third-party accrediting body as a competent laboratory pursuant to ISO/IEC 17025 of the International Organization for Standardization."

     SECTION 2.  New statutory material is underscored.

     SECTION 3.  This Act shall take effect on July 1, 2020.

 

INTRODUCED BY:

_____________________________

 

 


 


 

Report Title:

Cannabidiol Products; Product Safety; Packaging Requirements

 

Description:

Requires all cannabidiol products sold in the State to be tested by an independent testing laboratory for contaminants unsafe for human consumption and THC levels.  Requires the packaging on all cannabidiol products to contain information concerning THC levels and other product safety requirements.

 

 

 

The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.

feedback